EDGAR Filing Documents for 0001811764-22-000055

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001811764-22-000055

Filing Date

2022-05-16

Accepted

2022-05-16 08:27:19

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	a424b3andcombinedxhealthca.htm	424B3	30115
2	EX-99.1	healthcanadapressrelease-m.htm	EX-99.1	22239
3		image_0.jpg	GRAPHIC	48379
4		point-logoxcolour1.jpg	GRAPHIC	17537
	Complete submission text file	0001811764-22-000055.txt		144428

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22925695
SIC: 2834 Pharmaceutical Preparations